A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody
Response in Rabbits and Nonhuman Primates

Sin Nombre virus (SNV) and Andes virus (ANDV) cause most of the hantavirus pulmonary syndrome (HPS) cases in North and South America, respectively. The chances of a patient surviving HPS are only two in three. Previously, we demonstrated that SNV and ANDV DNA vaccines encoding the virus envelope gly...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwilas, Steve, Kishimori, Jennifer M., Josleyn, Matthew, Jerke, Kurt, Ballantyne, John, Royals, Michael, Hooper, Jay W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161193/
https://www.ncbi.nlm.nih.gov/pubmed/24867065
http://dx.doi.org/10.2174/1566523214666140522122633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161193/
https://www.ncbi.nlm.nih.gov/pubmed/24867065
http://dx.doi.org/10.2174/1566523214666140522122633

Ejemplares similares